What the evidence says
The sources on this page measure how an estimate changes when the analysis is restricted to a narrower set of comparable units. They cover three settings: indirect treatment comparisons, genetic analyses of sequential educational transitions, and meta-analyses limited to those with enough information. The designs differ, so the findings are not pooled.
In one indirect comparison of paracetamol plus codeine, the adjusted indirect estimate based on all trials was −1.16 (95% CI −6.95 to 4.64). The direct estimate was 7.28 (3.69 to 10.87), and the two differed at P=0.02. Restricting to trials that used 600-650 mg paracetamol and 60 mg codeine moved the adjusted indirect estimate to 5.72 (−5.37 to 16.81). That is no longer different from the direct estimate. The source attributes the original gap to many placebo-controlled trials using lower doses (300 mg paracetamol, 30 mg codeine). The authors conclude that trial similarity should be assessed carefully. Only this one case is examined in detail, so it is unknown whether other trial characteristics behave the same way.
In the genetic analyses, estimates fall at each later transition, where the at-risk group is progressively narrower. Observed-scale common-variant heritability (h2SNP) is about 0.14 for high school to bachelor's or higher (HS→BSc+). It falls to about 0.10 at BSc→MSc+ and about 0.07 at MSc→PhD. Polygenic index discrimination (Tjur's R2) is about 0.05 at HS→BSc+, about 0.03 at BSc→MSc+, and below 0.01 at MSc→PhD. Genetic correlation with the external EA4 educational attainment GWAS falls from 0.92 to 0.82 to 0.38 over the same transitions. Correlation with intelligence falls from 0.61 to 0.56 to 0.28. The MSc→PhD estimates are less precise, with an effective sample size of 8,185.
The source offers a selection mechanism for this attenuation. Selection into an already-selected at-risk group may narrow the residual variation in education-related characteristics available to distinguish further progression. The authors say the design cannot separate how much of the decline is selection and how much is true change in effects across milestones. The gap between twin-based and SNP-based heritability narrows from about 0.38 at high-school completion to about 0.11 at PhD on the liability scale. The twin and SNP estimates come from different cohorts, so the narrowing may reflect cohort differences and not only method.
A third body of evidence concerns meta-analyses that have not reached their required information size. It does not involve common-support restriction as such, but it shows the same pattern of published estimates changing when the underlying sample changes. Early meta-analyses often show large effects that shrink in later updates. A large simulation of random-effects meta-analyses shows a considerable risk of overestimating the effect before the required information size is reached. Among neonatal intervention meta-analyses, about 25% to 30% were false positive results. Naive 95% confidence intervals applied before that point are too narrow.